Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans.
D000328:Adult; D000368:Aged; D002297:Cardanolides / Q000494:pharmacology*; D005260:Female; D005470:Fluorometry; D006207:Half-Life; D006801:Humans; D007664:Ketosteroids / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D008901:Mineralocorticoids / Q000037:antagonists & inhibitors*; D011245:Pregnadienes / Q000494:pharmacology*; D011422:Propionates / Q000494:pharmacology; D013148:Spironolactone / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology* / Q000652:urine; D014316:Tritium
D002297:Cardanolides; D007664:Ketosteroids; D000451:Mineralocorticoid Receptor Antagonists; D008901:Mineralocorticoids; D011245:Pregnadienes; D011422:Propionates; D014316:Tritium; D013148:Spironolactone